Clinical Trial Update: Intravitreal Aflibercept Injection for Radiation Retinopathy Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating intravitreal aflibercept for radiation retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Retinopathy

Drugs mentioned

• intravitreal aflibercept (aflibercept)

Snippet

Sponsor: Amy C Schefler, MD | Conditions: Radiation Retinopathy | Phase 2 | Status: UNKNOWN